Literature DB >> 21067952

Rituximab therapy for AA-amyloidosis secondary to rheumatoid arthritis.

Javier Narváez, Maria Victoria Hernández, José Miguel Ruiz, Carmen Gómez Vaquero, Xavier Juanola, Joan Miquel Nollaa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21067952     DOI: 10.1016/j.jbspin.2010.09.020

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


× No keyword cloud information.
  4 in total

1.  Development of amyloidosis in patients with rheumatoid arthritis under TNF-blocking agents.

Authors:  Raquel Roque; Sofia Ramiro; Ana Cordeiro; Pedro Gonçalves; Silva Da Canas; Maria J Santos
Journal:  Clin Rheumatol       Date:  2011-04-12       Impact factor: 2.980

2.  Biologic therapy for amyloid A amyloidosis secondary to rheumatoid arthritis treated with interleukin 6 therapy: Case report and review of literature.

Authors:  Ju-Yang Jung; Young-Bae Kim; Ji-Won Kim; Chang-Hee Suh; Hyoun-Ah Kim
Journal:  Medicine (Baltimore)       Date:  2021-08-13       Impact factor: 1.817

3.  A multicenter report of biologic agents for the treatment of secondary amyloidosis in Turkish rheumatoid arthritis and ankylosing spondylitis patients.

Authors:  Ömer Nuri Pamuk; Umut Kalyoncu; Kenan Aksu; Ahmet Omma; Yavuz Pehlivan; Yonca Çağatay; Orhan Küçükşahin; Salim Dönmez; Gözde Yıldırım Çetin; Rıdvan Mercan; Özün Bayındır; Ayşe Çefle; Fatih Yıldız; Ayşe Balkarlı; Levent Kılıç; Necati Çakır; Bünyamin Kısacık; Mustafa Ferhat Öksüz; Veli Çobankara; Ahmet Mesut Onat; Mehmet Sayarlıoğlu; Mehmet Akif Öztürk; Gülsüm Emel Pamuk; Nurullah Akkoç
Journal:  Rheumatol Int       Date:  2016-05-24       Impact factor: 2.631

4.  Rituximab Therapy in Renal Amyloidosis Secondary to Rheumatoid Arthritis.

Authors:  Levent Kilic; Abdulsamet Erden; Yusuf Ziya Sener; Berkan Armagan; Alper Sari; Umut Kalyoncu; Omer Karadag; Ali Akdogan; Ismail Dogan; Sule Apras Bilgen; Sedat Kiraz; Ihsan Ertenli
Journal:  Biomolecules       Date:  2018-11-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.